Davis R M Inc. Decreases Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Davis R M Inc. lessened its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 12.7% in the third quarter, Holdings Channel reports. The firm owned 5,101 shares of the medical device company’s stock after selling 740 shares during the period. Davis R M Inc.’s holdings in Cooper Companies were worth $563,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in COO. Quent Capital LLC increased its holdings in Cooper Companies by 300.0% during the first quarter. Quent Capital LLC now owns 828 shares of the medical device company’s stock worth $84,000 after buying an additional 621 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Cooper Companies by 300.0% in the 1st quarter. Acadian Asset Management LLC now owns 720 shares of the medical device company’s stock worth $73,000 after purchasing an additional 540 shares during the period. O Shaughnessy Asset Management LLC lifted its stake in Cooper Companies by 443.6% in the first quarter. O Shaughnessy Asset Management LLC now owns 4,876 shares of the medical device company’s stock valued at $495,000 after purchasing an additional 3,979 shares during the last quarter. Lazard Asset Management LLC grew its holdings in Cooper Companies by 207.6% during the first quarter. Lazard Asset Management LLC now owns 4,759 shares of the medical device company’s stock valued at $482,000 after purchasing an additional 3,212 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its position in Cooper Companies by 302.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 283,380 shares of the medical device company’s stock worth $28,753,000 after buying an additional 212,908 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $102.40 on Tuesday. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The stock has a market cap of $20.39 billion, a PE ratio of 57.05, a PEG ratio of 2.17 and a beta of 0.99. The company’s fifty day moving average is $105.74 and its 200 day moving average is $98.39. The Cooper Companies, Inc. has a 52 week low of $82.21 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. During the same quarter in the previous year, the business earned $0.84 earnings per share. The company’s quarterly revenue was up 7.8% on a year-over-year basis. Research analysts anticipate that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Analyst Ratings Changes

Several research firms have recently weighed in on COO. Wells Fargo & Company increased their price target on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Morgan Stanley boosted their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Robert W. Baird raised their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Insiders Place Their Bets

In other news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. This represents a 24.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Daniel G. Mcbride sold 114,992 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at $4,714,534.08. The trade was a 72.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock valued at $27,637,427 in the last ninety days. Company insiders own 2.00% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.